Biosimilars Month in Review: April 2024
The biosimilars month in review reflects ongoing efforts to address key challenges in rheumatic disease treatment.
Source: hcplive.com
Biosimilars Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biosimilars Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biosimilars Act Today - Breaking & Trending Today
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act
In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.
Source: plos.org
Biologics and Biosimilars Landscape: IP, Policy, and Market Developments | Fish & Richardson
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...
Source: jdsupra.com
Increasing Legislative Changes May Mark Turning Point in US Biosimilar Adoption
Clinicians advocate for an at-parity approach to biosimilars, in which they, their patients, and the local market would have the freedom to choose the product that best suits their needs.
Source: hcplive.com
Washington Healthcare Update - December 2023 #2 | McGuireWoods Consulting
This Week in Washington: House Energy and Commerce Committee markup includes 19 healthcare bills; Senate HELP Committee to mark up SUPPORT Act Reauthorization and three other bills;...
Source: jdsupra.com